Plastic Bronchitis: Treatment Approach
For plastic bronchitis, particularly in Fontan patients, initiate aggressive airway clearance with chest physiotherapy and bronchoscopy for cast removal, combined with inhaled therapies (albuterol, hypertonic saline, tissue plasminogen activator), while urgently pursuing percutaneous lymphatic embolization to interrupt abnormal lymphatic connections—and refer immediately to advanced heart failure specialists, as heart transplantation remains the only definitive long-term cure 1.
Immediate Airway Management
The priority is preventing life-threatening airway obstruction and asphyxia. Bronchoscopy for direct cast removal is essential, used in 91% of non-single ventricle patients and 25% of Fontan patients 2. Flexible bronchoscopy is safe and enables assessment of cast burden without causing airway bleeding, obstruction, or prolonged intubation 3. Cryoprobe-assisted bronchoscopy improves cast extraction efficacy 4.
Chest physiotherapy should be initiated in virtually all patients (92% of single ventricle patients, 45% of non-single ventricle patients) 2 as a cornerstone of airway clearance.
Pharmacologic Therapy Algorithm
First-Line Inhaled Therapies:
- Albuterol: Use in 79% of single ventricle and 73% of non-single ventricle patients 2
- Inhaled corticosteroids: Particularly for single ventricle patients (75% usage) 2
- Nebulized hypertonic saline: Especially for single ventricle patients (29% usage) 2
Second-Line Fibrinolytic/Mucolytic Agents:
The evidence supports short-term fibrinolytic therapy based on cast composition. Neutrophilic proteinaceous casts (83% of analyzed casts) respond to fibrinolytics 3:
- Nebulized tissue plasminogen activator (tPA): Use in 33% of single ventricle patients 2
- Nebulized heparin: More common in non-single ventricle patients (55% vs 8%) 2
- Inhaled Dornase Alfa: Particularly for single ventricle patients (54% usage) 2
Anti-Infective Therapy:
Given that 8% had positive fungal, 11% bacterial, and 14% viral studies on BAL 3, empirical or targeted antimicrobial therapy is warranted when infection is suspected.
Systemic Corticosteroids:
Use selectively—more common in non-single ventricle patients (45%) than single ventricle patients (13%) 2.
Definitive Management of Lymphatic Dysfunction
Percutaneous lymphatic embolization to interrupt abnormal lymphatic connections has shown promise and is now the preferred intervention 1. This procedure has reduced the number of patients requiring transplant listing for plastic bronchitis 1. Alternative surgical approaches include thoracic duct ligation for refractory cases 5.
The pathophysiology involves proteinaceous material leaking into airways from abnormal lymphatic connections, forming bronchial-shaped casts 1. Advanced lymphatic imaging (dynamic contrast-enhanced MR lymphangiography, CT lymphangiography) guides intervention 6.
Critical Pitfall: Timing of Advanced Heart Failure Referral
Plastic bronchitis is an absolute indication for immediate referral to advanced heart failure specialists 1. While lymphatic interventions and airway clearance strategies have improved outcomes, success may be transient, and heart transplantation offers the only possibility of long-term cure 1.
Late referral has grave consequences—patients may become ineligible for transplant due to sarcopenia and frailty from chronic disease 1. The median BAL neutrophil count correlates with proteinaceous neutrophilic/eosinophilic casts (P = 0.030) 3, suggesting inflammation drives cast formation.
Post-Intervention Monitoring
Following lymphatic intervention, expect significant reduction in:
- Respiratory medications and support requirements
- Casting frequency
- Need for bronchoscopic interventions 3
Median follow-up data at 20 months demonstrates sustained benefit 3, though vigilance for recurrence remains essential given the underlying Fontan hemodynamic abnormalities that drive lymphatic dysfunction.
Context-Specific Considerations
For Fontan patients: The constellation of elevated Fontan pressures, low cardiac output, and abnormal lymphatic drainage creates the substrate for plastic bronchitis 1. These patients require comprehensive hemodynamic assessment alongside airway management.
For non-cardiac patients: Plastic bronchitis may be associated with inflammatory lung diseases, occupational exposures, infections (including atypical presentations of Bordetella pertussis) 7, or idiopathic causes 8, 9. The treatment approach emphasizes bronchoscopy (91% usage) and nebulized heparin (55% usage) over the lymphatic-focused interventions used in cardiac patients 2.